Peptide Research Library
A curated collection of peer-reviewed publications and community observations supporting the scientific investigation of bioactive peptides.
Featured Research Articles
Published Research
Gastric Pentadecapeptide BPC 157 and Musculoskeletal Soft Tissue Healing
Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019 Aug;377(2):153-159. doi: 10.1007/s00441-019-03016-8. Epub 2019 Mar 27. PMID: 30915550. (2019)
Cell and Tissue Research
This 2019 review by Gwyer, Wragg and Wilson examines BPC 157's role in accelerating the repair of musculoskeletal soft tissues including tendons, ligaments, and muscle. The authors detail how BPC 157 modulates growth factor expression, promotes angiogenesis, and enhances fibroblast migration — supporting its potential as a therapeutic compound for soft tissue injuries that are notoriously slow to heal.
Thymosin Beta 4 Accelerates Wound Healing
Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999 Sep;113(3):364-8. doi: 10.1046/j.1523-1747.1999.00708.x. PMID: 10469335. (1999)
Journal of Investigative Dermatology
This study by Malinda et al. demonstrated that Thymosin Beta 4 (Tβ4) significantly accelerates full-thickness wound healing in animal models. Tβ4 promoted keratinocyte and endothelial cell migration, collagen deposition, and angiogenesis — resulting in faster wound closure compared to controls. The findings established Tβ4 as a potent promoter of tissue repair with broad regenerative implications.
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways
Pickart, L. et al. (2015)
BioMed Research International
GHK-Cu tripeptide shown to regulate gene expression of over 4,000 human genes, with significant effects on wound healing, tissue remodeling, anti-inflammatory activity, and antioxidant defense.
Selank: An Anxiolytic Peptide with Nootropic Properties
Kozlovskii, I.I. et al. (2003)
Neuroscience and Behavioral Physiology
Clinical investigation of Selank's effects on anxiety and cognitive function, demonstrating modulation of BDNF expression and GABAergic neurotransmission without sedative effects.
Thymosin Beta 4: A Multi-functional Regenerative Peptide
Goldstein, A.L. et al. (2012)
Expert Opinion on Biological Therapy
Review of TB-500/Thymosin Beta-4 in tissue repair, wound healing, and cardiac regeneration. Demonstrated promotion of cell migration, stem cell differentiation, and anti-inflammatory effects.
Epitalon and Telomerase Activity in Human Somatic Cells
Khavinson, V.K. et al. (2003)
Bulletin of Experimental Biology and Medicine
Investigation of the tetrapeptide Epithalon (AEDG) showing activation of telomerase in human somatic cells, with implications for age-related cellular senescence and longevity research.
CJC-1295 and Ipamorelin: Growth Hormone Secretagogues
Teichman, S.L. et al. (2006)
Journal of Clinical Endocrinology & Metabolism
Clinical study of modified GRF (CJC-1295) demonstrating sustained increases in growth hormone and IGF-1 levels with improved pharmacokinetic profiles through albumin binding.
Retatrutide (GGG Tri-agonist) Phase 2 Trial for Obesity
Jastreboff, A.M. et al. (2023)
New England Journal of Medicine
Phase 2 randomized controlled trial demonstrating up to 24.2% mean body weight reduction over 48 weeks with Retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, representing a new frontier in metabolic peptide research.
Tirzepatide vs Semaglutide: SURMOUNT-5 Trial
Jastreboff, A.M. et al. (2025)
New England Journal of Medicine
Head-to-head comparison showing tirzepatide (dual GIP/GLP-1 agonist) achieved superior weight reduction compared to semaglutide in adults with obesity, reinforcing the role of multi-receptor agonism in metabolic peptide therapy.
Semaglutide and Cardiovascular Outcomes in Obesity (SELECT Trial)
Lincoff, A.M. et al. (2023)
New England Journal of Medicine
Landmark cardiovascular outcomes trial showing semaglutide 2.4mg reduced major adverse cardiovascular events by 20% in adults with overweight/obesity without diabetes, establishing GLP-1 agonists as a class with systemic metabolic benefits.
Community Observations
The following are summarized observational reports from research communities. These are not clinical findings and should be interpreted with appropriate scientific caution.
Multiple athlete-researchers have documented accelerated healing timelines for tendon and ligament injuries, with some reporting noticeable improvement within 2-4 weeks of research protocols.
Community research forums, 2020-2024
Dermatological researchers note improved skin elasticity and reduced fine lines in observational studies. Many report visible skin texture improvements within 6-8 weeks of topical application protocols.
Skincare research communities, 2019-2024
Longevity researchers consistently report increased energy levels, improved exercise capacity, and enhanced cognitive function when investigating NAD+ pathway modulation.
Longevity research networks, 2018-2024
Neuroscience researchers report reduced anxiety symptoms and enhanced focus without the sedation or dependency risks commonly associated with traditional anxiolytic compounds.
Nootropic research communities, 2017-2024
Explore Our Peptide Collection
Each product in our catalog includes relevant research references and detailed specifications.
Browse Products